Arimidex 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FX41R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,245
Award facts
- Contract value 100% obligated
- $2,244.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,244.92 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on September 7, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with extensive experience fulfilling DLA Medical Supply Chain requirements. The company's federal portfolio encompasses diverse pharmaceutical products including specialty medications, branded and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Arimidex, a hormone therapy medication commonly used in cancer treatment, exemplifies the company's role in supplying essential pharmaceuticals to support Defense Health Agency and other federal healthcare systems. AmerisourceBergen's selection through open competition underscores its capability to meet federal procurement standards and its significance as a strategic partner in the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FX41R?
SPE2DB25FX41R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 7, 2025.
How much is contract SPE2DB25FX41R worth?
The government has obligated $2,245 on SPE2DB25FX41R.
Is contract SPE2DB25FX41R an order under another contract?
Yes. SPE2DB25FX41R is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX41R competed?
The extent of competition for SPE2DB25FX41R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award